Navigation Links
Heparin Antibodies May Put Patients At Risk

Patients developing antibodies to heparin, an anti-clotting drug, run the risk of either serious complications after undergoing a heart surgery, or death, according to a new research // . The Wake Forest University Baptist Medical Center’s professor of anesthesiology Thomas Slaughter said that the study aimed at finding out if an independent risk is posed by the development of heparin antibodies prior to the surgery.

Heparin is used in several procedures like heart catheterization or angioplasty, kidney dialysis, in addition to heart and vascular surgeries. Antibodies are developed in as many as 50% of the patients who are treated with heparin, the effect of which may even last for several months. The researchers are of the opinion that blood components are activated which cause inflammation and clotting in the case of subsequent treatment on patients who already carry heparin antibodies.

This will also lead to increased risks of strokes, heart rhythm problems, heart attacks, and other complications. The heparin antibody levels in the patients were studied by the researchers, before surgery, who came to the conclusion that the risk of hospitalization or death was twofold in the case of patients with the antibodies.

The Parsonnet risk score, a standardized risk scoring system was also used by the research scientists to ensure that the results of the study were not influenced by the baseline health status of the patients. The heparin antibodies were found in 13% of the patients who were to undergo surgery in the US.

Heparin can be easily be replaced by many other anti-clotting medications, but the Food and Drug Administration of the country will have to approve of them before they can be used. Patients may also postpone the surgery until the antibody levels in their bodies have subsided, which may at times take months together, and may not be practical if the patient concerned requires surgery immediately.


'"/>




Page: 1

Related medicine news :

1. Complications In Kidney Failure Patients Linked To Heparin
2. Heparin does not protect from recurrent heart attacks
3. Heparin Based Nanoscale Materials Developed For Dialysis Treatment
4. Ordinary Heparin as Effective as Expensive Blood Thinner
5. Antibodies to fight HIV infection.
6. Survival of Mice With Human Breast Cancer Extended by Monoclonal Antibodies
7. Scientists Develop Antibodies from Plant Seeds
8. Antibodies in Mother Affect Heart of Fetus
9. One in Three Heart Attack Patients Have No Chest Pains
10. Amphetamines Help Recovery of Stroke Patients
11. Painkillers Do Not Shorten Dying Patients Lives
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/18/2018)... ... October 18, 2018 , ... ... care, cancer and hematology, and a comprehensive Women’s Center, Mount Sinai Doctors Long ... complex at 5 Cuba Hill Road in Greenlawn, Suffolk County. , With ...
(Date:10/18/2018)... ... , ... Fellow Health Partners, Inc. , a New York based medical ... agreed to join its Advisory Board. , CEO Michael N. Brown said, “This advisory ... guide Fellow Health Partners. They will provide strategic as well as tactical, ‘front lines’ ...
(Date:10/17/2018)... ... , ... The Jacobs & Cushman San Diego Food Bank’s CEO, James Floros, ... of its Board of Directors. , California Association of Food Banks (CAFB) is ... its member food banks with a range of support services, direct service programs and ...
(Date:10/16/2018)... ... October 16, 2018 , ... CCC ( ... midstream and downstream operators today announces Total Train Comprehensive Release version 14.1 (TTCR ... critical system components focused on improving cybersecurity defense around turbomachinery. The upgrade ...
(Date:10/16/2018)... ... October 16, 2018 , ... Bastyr University is pleased announce ... Health and Medicine’s (AIHM) Visionary Award for his passionate efforts in forging a ... selected as AIHM’s recipient of the Visionary Award due to his tireless effort ...
Breaking Medicine News(10 mins):
(Date:10/18/2018)... ... 18, 2018 , ... Physicians with Georgia Urology, the largest ... nationwide using Blue Light Cystoscopy with Cysview. This assists in detecting papillary cancer ... the only FDA-approved imaging agent for use with blue-light cystoscopy. , Georgia Urology ...
(Date:10/17/2018)... , ... October 17, 2018 , ... ... has recently published a new technique documenting the use of placental based growth ... implants. According to Dr. Holtzclaw, “At our DIA Dental Implant Center locations ...
(Date:10/17/2018)... (PRWEB) , ... October 17, 2018 , ... ... Commission for Health Care (ACHC) President and CEO José Domingos to its board ... welcome José Domingos to our Board of Directors, whose broad and varied stakeholder ...
Breaking Medicine Technology: